Jonathan Tobin prior to joining Brandon was a Managing Director at Arix Bioscience, a UK and US-based biotech venture firm. Prior to working at Arix, Jonathan spent five years at UK early-stage venture capital firm Touchstone Innovations, where he was a Principal in the Healthcare Ventures team. He also worked at LifeArc, sourcing and evaluating new small molecule and antibody drug discovery projects. Jonathan has a degree in Biology from the University of Oxford, a PhD in Molecular Medicine from University College London (UCL) focusing on genetic disease genetics and therapeutics; carried out postdoctoral research on cancer cell signaling at the Crick Institute, and has an MBA Imperial College London.

WordPress Cookie Notice by Real Cookie Banner